Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong
SHANGHAI, Dec 2, 2024 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical […]